Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

In vitro comprehensive analysis of VA692 a new chemical entity for the treatment of osteoarthritis.

Cheleschi S, Calamia V, Fernandez-Moreno M, Biava M, Giordani A, Fioravanti A, Anzini M, Blanco F.

Int Immunopharmacol. 2018 Aug 25;64:86-100. doi: 10.1016/j.intimp.2018.08.025. [Epub ahead of print]

PMID:
30153531
2.

Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition.

Fioravanti A, Tenti S, Bacarelli MR, Damiani A, Li Gobbi F, Bandinelli F, Cheleschi S, Galeazzi M, Benucci M.

Clin Exp Rheumatol. 2018 Aug 27. [Epub ahead of print]

PMID:
30148441
3.

Could Oxidative Stress Regulate the Expression of MicroRNA-146a and MicroRNA-34a in Human Osteoarthritic Chondrocyte Cultures?

Cheleschi S, De Palma A, Pascarelli NA, Giordano N, Galeazzi M, Tenti S, Fioravanti A.

Int J Mol Sci. 2017 Dec 8;18(12). pii: E2660. doi: 10.3390/ijms18122660.

4.

Hydrostatic pressure as epigenetic modulator in chondrocyte cultures: A study on miRNA-155, miRNA-181a and miRNA-223 expression levels.

De Palma A, Cheleschi S, Pascarelli NA, Giannotti S, Galeazzi M, Fioravanti A.

J Biomech. 2018 Jan 3;66:165-169. doi: 10.1016/j.jbiomech.2017.10.044. Epub 2017 Nov 7.

PMID:
29150345
5.

Hydrostatic Pressure Regulates MicroRNA Expression Levels in Osteoarthritic Chondrocyte Cultures via the Wnt/β-Catenin Pathway.

Cheleschi S, De Palma A, Pecorelli A, Pascarelli NA, Valacchi G, Belmonte G, Carta S, Galeazzi M, Fioravanti A.

Int J Mol Sci. 2017 Jan 12;18(1). pii: E133. doi: 10.3390/ijms18010133.

6.

Do MicroRNAs have a key epigenetic role in osteoarthritis and in mechanotransduction?

De Palma A, Cheleschi S, Pascarelli NA, Tenti S, Galeazzi M, Fioravanti A.

Clin Exp Rheumatol. 2017 May-Jun;35(3):518-526. Epub 2017 Jan 4. Review.

PMID:
28079507
7.

Effect of Mud-Bath Therapy on Serum Biomarkers in Patients with Knee Osteoarthritis: Results from a Randomized Controlled Trial.

Pascarelli NA, Cheleschi S, Bacaro G, Guidelli GM, Galeazzi M, Fioravanti A.

Isr Med Assoc J. 2016 Mar-Apr;18(3-4):232-7.

8.

Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients.

Correale P, Botta C, Martino EC, Ulivieri C, Battaglia G, Carfagno T, Rossetti MG, Fioravanti A, Guidelli GM, Cheleschi S, Gandolfo C, Carbone F, Baldari TC, Tassone P, Tagliaferri P, Pirtoli L, Cusi MG.

Oncoimmunology. 2015 Dec 21;5(4):e1101205. eCollection 2016 Apr.

9.

The Emerging Role of Bradykinin in the Pathogenesis of Osteoarthritis and its Possible Clinical Implications.

Tenti S, Pascarelli NA, Cheleschi S, Guidelli GM, Fioravanti A.

Curr Rheumatol Rev. 2016;12(3):177-184. Review.

PMID:
27030254
10.

Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature.

Tenti S, Cheleschi S, Guidelli GM, Galeazzi M, Fioravanti A.

Autoimmun Rev. 2016 Mar;15(3):226-35. doi: 10.1016/j.autrev.2015.11.009. Epub 2015 Dec 1. Review.

PMID:
26656906
11.

Changes in Ultrastructure and Cytoskeletal Aspects of Human Normal and Osteoarthritic Chondrocytes Exposed to Interleukin-1β and Cyclical Hydrostatic Pressure.

Pascarelli NA, Collodel G, Moretti E, Cheleschi S, Fioravanti A.

Int J Mol Sci. 2015 Oct 30;16(11):26019-34. doi: 10.3390/ijms161125936.

12.

Chondroprotective effect of three different classes of anti-inflammatory agents on human osteoarthritic chondrocytes exposed to IL-1β.

Cheleschi S, Pascarelli NA, Valacchi G, Di Capua A, Biava M, Belmonte G, Giordani A, Sticozzi C, Anzini M, Fioravanti A.

Int Immunopharmacol. 2015 Sep;28(1):794-801. doi: 10.1016/j.intimp.2015.07.003. Epub 2015 Aug 26.

PMID:
26292179
13.

Circulating levels of adiponectin, resistin, and visfatin after mud-bath therapy in patients with bilateral knee osteoarthritis.

Fioravanti A, Giannitti C, Cheleschi S, Simpatico A, Pascarelli NA, Galeazzi M.

Int J Biometeorol. 2015 Nov;59(11):1691-700. doi: 10.1007/s00484-015-0977-y. Epub 2015 Mar 7.

PMID:
25750093
14.

Possible chondroprotective effect of canakinumab: an in vitro study on human osteoarthritic chondrocytes.

Cheleschi S, Cantarini L, Pascarelli NA, Collodel G, Lucherini OM, Galeazzi M, Fioravanti A.

Cytokine. 2015 Feb;71(2):165-72. doi: 10.1016/j.cyto.2014.10.023. Epub 2014 Nov 17.

PMID:
25461395
15.

Spa therapy: can be a valid option for treating knee osteoarthritis?

Tenti S, Cheleschi S, Galeazzi M, Fioravanti A.

Int J Biometeorol. 2015 Aug;59(8):1133-43. doi: 10.1007/s00484-014-0913-6. Epub 2014 Oct 23. Review.

PMID:
25339582
16.

What about strontium ranelate in osteoarthritis? Doubts and securities.

Tenti S, Cheleschi S, Guidelli GM, Galeazzi M, Fioravanti A.

Mod Rheumatol. 2014 Nov;24(6):881-4. doi: 10.3109/14397595.2014.888156. Epub 2014 Mar 19. Review.

PMID:
24645726

Supplemental Content

Loading ...
Support Center